Continuing an anxiety medication after a previous study
Part of Mental health clinical trials.
This study is for adults who already completed an earlier phase 3 trial of this anxiety medication and are continuing it. It tests how safe and tolerable the medication is when used for a longer period for generalized anxiety disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You completed a previous phase 3 study of this medication and finished the full 8-week treatment
- Your doctor thinks continuing the medication could help you
- You are willing to follow the study schedule and use birth control if needed
- You do not have other major psychiatric or medical conditions that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
This trial tests a new medication, JNJ-99245354 (also called ITI-1284), added to your current anxiety treatment to see if it helps reduce anxiety symptoms. You may be eligible if you've already tried at least one FDA-approved treatment for generalized anxiety disorder without enough improvement.
This study is testing a new medication for generalized anxiety disorder. It will check if the drug is safe and well-tolerated when taken alone or alongside your current anxiety treatment.
This study tests an investigational oral medication (ITI-1284) for people with moderate to severe generalized anxiety disorder (GAD) who haven't found enough relief from at least two standard medications. The goal is to see if this new drug helps reduce anxiety symptoms.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.